HEMOPSIS is a medtech spin-off of the University of Porto (FEUP/CEFT) and 2CA-Braga, developing SHECAD — Sex-aware Hemodynamic predictors of Coronary Artery Disease. SHECAD reconstructs coronary hemodynamics from angiography data already collected in routine clinical practice.
Coronary artery disease is among the leading causes of death worldwide, yet the vascular anatomy, hemodynamics, and disease progression of male and female patients differ in ways most diagnostic and modeling tools were never built to capture. As a result, risk assessment and treatment planning can miss patient-specific detail that matters clinically.
Most computational hemodynamic tools available today also model a single anatomical snapshot — one moment in time — rather than how disease actually develops.
Hospitals already perform invasive coronary angiography (ICA) as part of routine care. That data holds more information than standard workflows extract — including the biomechanical signal needed for sex-differentiated, longitudinal risk assessment.
SHECAD reconstructs coronary hemodynamics from invasive coronary angiography (ICA) already performed in routine clinical practice — no additional imaging or procedure required. It is built on a longitudinal dataset with double follow-up, developed in collaboration with 2CA-Braga.
Modeling how coronary hemodynamics evolve over time, rather than a single anatomical snapshot.
Accounting for known anatomical and hemodynamic differences between male and female patients — an axis largely absent from existing tools.
Tracking how disease progresses to support earlier, more personalized clinical decisions.
Auxiliar Investigador at FEUP–CEFT, specialised in cardiovascular hemodynamics, computational fluid dynamics, and patient-specific modelling of coronary artery disease. PhD in Chemical Engineering (2016); combines CFD, clinical imaging, and AI-driven methodologies for predictive and translational cardiovascular tools.
CFD researcher at the University of Porto and member of the CEFT/ALICE research group, with expertise in multiphase flows, transport phenomena, and numerical modelling — more recently applying generative AI to image analysis and super-resolution in fluid dynamics.
Interventional cardiologist at the Hemodynamics Service of ULS-Braga. Leads one of the largest coronary angiography registries in Portugal and contributes to translational cardiovascular research through longitudinal clinical data analysis.
R&D Manager at Bondalti (previously Bosch, Efacec, FEUP) — over 15 years leading industrial innovation, technology and business-case development, financing, and delivery of large-scale projects.
International executive across critical infrastructure and industrial operations, currently focused on data-center expansion strategy at Google — strong background in strategic development and business development.
AI specialist, entrepreneur, and technology leader with expertise in generative AI, LLMs, and data science. Co-founder and former CTO of a software company through to acquisition.
Clinical Academic Center — clinical partner, providing cardiology expertise and access to the clinical data underpinning SHECAD's development and validation.
Centro de Estudos de Fenómenos de Transporte, Faculty of Engineering, University of Porto — scientific and research partner behind the computational and biomechanical modelling.
For partnership, clinical collaboration, or investment conversations, reach out directly.
